title: Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.
abstract: Angiotensin converting enzyme (ACE) inhibitors have been recommended for the treatment of diabetic nephropathy. However, it should be remembered that diabetic patients may also develop atheromatous renal artery stenosis. In such patients ACE inhibitors may have adverse effects on renal function. Careful investigation and monitoring is essential when ACE inhibitors are used in diabetes.
authors.affiliation: Department of Medicine and Therapeutics, Aberdeen Royal Infirmary.
authors.forename: J
authors.initials: J
authors.lastname: Webster
authors.forename: L E
authors.initials: LE
authors.lastname: Murchison
authors.forename: O J
authors.initials: OJ
authors.lastname: Robb
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D002216:Captopril / Q000009:adverse effects; D048909:Diabetes Complications; D004656:Enalapril / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012078:Renal Artery Obstruction / Q000150:complications* / Q000209:etiology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D002216:Captopril